Laboratory

A classification of the seriousness or clinical urgency of a hematologic finding or condition, such as mild, moderate, or severe anemia based on hemoglobin thresholds. Used in clinical triage systems, care management platforms, and reporting tools to prioritize interventions and track disease burden over time.

The biological sex of the patient associated with a hematology study or blood panel result. Used to apply sex-specific reference ranges for CBC components such as hemoglobin, hematocrit, and red blood cell counts, where normal values differ between male and female patients.

Identifies the originating system, facility, or specimen collection point from which hematology laboratory data was received. Used in clinical data integration to trace blood study results back to the submitting laboratory, hospital department, or external reference lab for audit and reconciliation purposes.

The calendar date on which a hematology study, blood panel order, or related treatment protocol was initiated. Used in clinical tracking to establish the timeline of a patient's hematologic evaluation, monitor ongoing conditions such as anemia or clotting disorders, and support longitudinal analysis.

The time of day at which a hematology study or blood specimen collection was initiated. Used in clinical workflows to sequence laboratory events, calculate turnaround times from collection to result, and ensure accurate timestamping of blood panel data within the patient's clinical record.

The U.S. state or Canadian province associated with the facility or laboratory where a hematology study was conducted or ordered. Used in geographic reporting, regulatory compliance tracking, and analysis of laboratory service distribution across regional health networks.

Indicates the current processing or result state of a hematology study, such as ordered, in-progress, resulted, corrected, or cancelled. Used in laboratory information systems to track workflow progression of blood panels and alert clinicians when results are finalized or require follow-up action.

The physical street address of the facility, clinic, or laboratory where a hematology study was ordered or performed. Used in laboratory data management to associate blood study records with specific collection or testing sites for reporting, billing, and network analysis purposes.

The concentration or dosage strength of a medication or therapeutic agent administered in conjunction with a hematology study, such as iron supplements, erythropoietin, or chemotherapy drugs. Used to correlate treatment dosage with resulting blood panel values during hematologic condition management.

A partial aggregate value derived from a subset of hematology study results or associated charges, such as a subtotal of specific blood panel components or laboratory fees. Used in clinical reporting and billing workflows to break down composite hematology encounter data into meaningful grouped summaries.

A system-generated unique identifier assigned to a hematology study record within a laboratory information system or clinical data warehouse. Used to uniquely reference and link blood panel orders, results, and related clinical events across disparate healthcare systems and data integration pipelines.

The intended destination system, receiving facility, or clinical threshold target associated with a hematology study. Used in data routing workflows and clinical decision support to direct blood panel results to the appropriate care team or to define therapeutic targets for hematologic parameters such as hemoglobin levels.

The NUCC taxonomy code identifying the clinical specialty of the ordering or performing clinician associated with a hematology study, such as a hematologist or oncologist. Used in claims processing and credentialing to validate that blood panel services were rendered by appropriately classified clinical specialists.

The patient's body temperature recorded at the time of a hematology study or specimen collection. Used as a clinical contextual variable in blood panel interpretation, particularly relevant in fever workups, infectious disease evaluations, and monitoring conditions such as neutropenic fever or sepsis.

The calendar date on which a hematology study protocol, treatment course, or monitoring program was concluded or discontinued. Used in clinical data systems to define the endpoint of a patient's hematologic evaluation period and support longitudinal outcome analysis and treatment duration reporting.

The specific time of day associated with a hematology event, such as specimen collection, result release, or clinician review. Used in laboratory workflows to sequence blood study activities, calculate processing intervals, and ensure accurate temporal documentation within the patient's clinical encounter record.

The combined date and time value capturing when a hematology study event occurred, such as specimen collection, laboratory processing, or result finalization. Used in clinical data warehouses and laboratory systems to establish precise chronological records for blood panel auditing, reporting, and patient safety review.

The formal name or descriptive label assigned to a hematology study, panel, or protocol, such as Complete Blood Count, Comprehensive Metabolic Panel with Differential, or Bone Marrow Biopsy. Used in clinical documentation and reporting to clearly identify the type of blood study ordered or performed.

The aggregate sum of values associated with a hematology study, such as total white blood cell count, total billed charges, or total number of component results within a blood panel. Used in clinical reporting and financial analytics to summarize hematology encounter data at the study or encounter level.

The total number of discrete hematology study records, individual blood panel components, or specimen events within a defined dataset or reporting period. Used in population health analytics and laboratory management reporting to quantify the volume of hematologic testing activity across patients or time intervals.